These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 17062131

  • 1. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
    Wu TJ, Lee LY, Yeh CN, Wu PY, Chao TC, Hwang TL, Jan YY, Chen MF.
    BMC Gastroenterol; 2006 Oct 24; 6():29. PubMed ID: 17062131
    [Abstract] [Full Text] [Related]

  • 2. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H, Zhang Y, Wang M, Shen DP, Sheng ZY, Ni XZ, Wu ZY, Liu Q, Shen YY, Song YY.
    Chin Med J (Engl); 2010 Jan 20; 123(2):131-6. PubMed ID: 20137358
    [Abstract] [Full Text] [Related]

  • 3. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W.
    Med Sci Monit; 2007 Nov 20; 13(11):CR515-522. PubMed ID: 17968300
    [Abstract] [Full Text] [Related]

  • 4. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
    Yang F, Jin C, Du Z, Subedi S, Jiang Y, Li J, Di Y, Zhou Z, Tang F, Fu D.
    Am J Surg; 2013 Sep 20; 206(3):360-7. PubMed ID: 23673012
    [Abstract] [Full Text] [Related]

  • 5. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P, Wozniak A, Dębiec-Rychter M, Kąkol M, Dziewirski W, Zdzienicki M, Ptaszynski K, Jurkowska M, Limon J, Siedlecki JA.
    Cancer; 2011 Nov 01; 117(21):4916-24. PubMed ID: 21456019
    [Abstract] [Full Text] [Related]

  • 6. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6727-34. PubMed ID: 18006774
    [Abstract] [Full Text] [Related]

  • 7. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM, Li XH, Chen W.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 15; 88(15):1041-5. PubMed ID: 18754437
    [Abstract] [Full Text] [Related]

  • 8. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
    Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Schöffski P, Bauer S, Fumagalli E, Nyckowski P, Nguyen BP, Kerst JM, Fiore M, Bylina E, Hoiczyk M, Cats A, Casali PG, Le Cesne A, Treckmann J, Stoeckle E, de Wilt JH, Sleijfer S, Tielen R, van der Graaf W, Verhoef C, van Coevorden F.
    Ann Surg Oncol; 2013 Sep 15; 20(9):2937-43. PubMed ID: 23760587
    [Abstract] [Full Text] [Related]

  • 9. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    Chirieac LR, Trent JC, Steinert DM, Choi H, Yang Y, Zhang J, Patel SR, Benjamin RS, Raymond AK.
    Cancer; 2006 Nov 01; 107(9):2237-44. PubMed ID: 16998931
    [Abstract] [Full Text] [Related]

  • 10. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, Singer S, Besmer P, Brennan MF, Antonescu CR.
    Cancer; 2008 Feb 01; 112(3):608-15. PubMed ID: 18076015
    [Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
    Bauer S, Rutkowski P, Hohenberger P, Miceli R, Fumagalli E, Siedlecki JA, Nguyen BP, Kerst M, Fiore M, Nyckowski P, Hoiczyk M, Cats A, Casali PG, Treckmann J, van Coevorden F, Gronchi A.
    Eur J Surg Oncol; 2014 Apr 01; 40(4):412-9. PubMed ID: 24491288
    [Abstract] [Full Text] [Related]

  • 12. Clinical, pathological and surgical characteristics of duodenal gastrointestinal stromal tumor and their influence on survival: a multi-center study.
    Colombo C, Ronellenfitsch U, Yuxin Z, Rutkowski P, Miceli R, Bylina E, Hohenberger P, Raut CP, Gronchi A.
    Ann Surg Oncol; 2012 Oct 01; 19(11):3361-7. PubMed ID: 22843188
    [Abstract] [Full Text] [Related]

  • 13. [Gastrointestinal stromal tumour: our experience].
    Versaci A, Macrì A, Ieni A, Terranova M, Leonello G, Saladino E, Speciale G, Famulari C.
    Chir Ital; 2009 Oct 01; 61(2):161-9. PubMed ID: 19536989
    [Abstract] [Full Text] [Related]

  • 14. Surgical management of rectal gastrointestinal stromal tumors.
    Tielen R, Verhoef C, van Coevorden F, Reyners AK, van der Graaf WT, Bonenkamp JJ, van Etten B, de Wilt JH.
    J Surg Oncol; 2013 Mar 01; 107(4):320-3. PubMed ID: 22806955
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE, Kim MA, Lee HS, Lee BL, Kim WH.
    J Clin Pathol; 2008 Jun 01; 61(6):722-9. PubMed ID: 18381383
    [Abstract] [Full Text] [Related]

  • 16. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
    Jakob J, Mussi C, Ronellenfitsch U, Wardelmann E, Negri T, Gronchi A, Hohenberger P.
    Ann Surg Oncol; 2013 Feb 01; 20(2):586-92. PubMed ID: 22965573
    [Abstract] [Full Text] [Related]

  • 17. Gastrointestinal stromal tumors treatment in the Imatinib era. The role of fair indication.
    Vendettuoli M, Pironi D, Pontone S, Panarese A, La Gioia G, Arcieri S, Romani AM, Palazzini G, Filippini A.
    Minerva Chir; 2012 Apr 01; 67(2):165-73. PubMed ID: 22487918
    [Abstract] [Full Text] [Related]

  • 18. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink HH, Bonenkamp JJ, van der Graaf WT, de Wilt JH.
    Eur J Surg Oncol; 2013 Feb 01; 39(2):150-5. PubMed ID: 23084087
    [Abstract] [Full Text] [Related]

  • 19. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.
    Rossi S, Miceli R, Messerini L, Bearzi I, Mazzoleni G, Capella C, Arrigoni G, Sonzogni A, Sidoni A, Toffolatti L, Laurino L, Mariani L, Vinaccia V, Gnocchi C, Gronchi A, Casali PG, Dei Tos AP.
    Am J Surg Pathol; 2011 Nov 01; 35(11):1646-56. PubMed ID: 21997685
    [Abstract] [Full Text] [Related]

  • 20. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
    An JY, Choi MG, Noh JH, Sohn TS, Kang WK, Park CK, Kim S.
    Eur J Surg Oncol; 2007 Oct 01; 33(8):1030-5. PubMed ID: 17428635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.